EZH2 and diffuse large B-cell lymphoma: Indeed, approximately 1 in 4 FL and GCB-DLBCL tumors present heterozygous gain-of-function (GOF) mutations in EZH2, resulting in elevated H3K27 trimethylation (H3K27me3) [6,7].